Rates of dose adjustment in patients treated with tivozanib versus sorafenib in the phase III TIVO-1 study Meeting Abstract


Authors: Hutson, T. E.; Nosov, D.; Harza, M.; Esteves, B.; Strahs, A. L.; Berkenblit, A.; Motzer, R. J.
Abstract Title: Rates of dose adjustment in patients treated with tivozanib versus sorafenib in the phase III TIVO-1 study
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601578
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.4564
Notes: Meeting Abstract: 4564 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer